Anne Lok

机构：Centre Hospitalier Universitaire de Nantes, Centre d'Investigation Clinique de Nantes, Nantes Université

发表论文 60 篇 · 总被引 568 次 · h-index 15

代表论文

• Inotuzumab Ozogamicin and Low-Intensity Chemotherapy in Older Patients With Newly Diagnosed CD22 + Philadelphia Chromosome–Negative B-Cell Precursor Acute Lymphoblastic Leukemia (2024 · Journal of Clinical Oncology · 被引 39)
• Safety and immunogenicity of a first dose of SARS‐CoV‐2 mRNA vaccine in allogeneic hematopoietic stem‐cells recipients (2021 · eJHaem · 被引 39)
• Safety and antibody response after one and/or two doses of BNT162b2 Anti‐SARS‐CoV‐2 mRNA vaccine in patients treated by CAR T cells therapy (2021 · British Journal of Haematology · 被引 31)
• Interest of a third dose of BNT162b2 anti‐SARS‐CoV‐2 messenger RNA vaccine after allotransplant (2021 · British Journal of Haematology · 被引 30)
• A new cytokine‐based dynamic stratification during induction is highly predictive of survivals in acute myeloid leukemia (2020 · Cancer Medicine · 被引 16)
• B Cell Aplasia Is the Most Powerful Predictive Marker for Poor Humoral Response after BNT162b2 mRNA SARS-CoV-2 Vaccination in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation (2022 · Transplantation and Cellular Therapy · 被引 14)